検索結果

发表论文 | 研究与开发 | 千寿制药株式会社

2025 Effects of dihydrocapsiateonsalivary secretion in healthy subjects:A randomized, double-blind, placebo-controlled, crossover study Keisuke Yoshida1, Ryuji Takeda2, and Osamu Sakai1. 1 Senju Pharm...

Meetings of the Minds | Research & Development | SENJU Pharmaceutica

USA Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu...

学会発表実績 | 研究開発活動 | 千寿製薬株式会社

USA Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu...

論文投稿実績 | 研究開発活動 | 千寿製薬株式会社

2025 Effects of dihydrocapsiateonsalivary secretion in healthy subjects:A randomized, double-blind, placebo-controlled, crossover study Keisuke Yoshida1, Ryuji Takeda2, and Osamu Sakai1. 1 Senju Pharm...

eal sensory nerves 1) . *2 3-02 clinical trial A Phase III, multicenter, randomized, double-masked, placebo-controlled, parallel-group study in patients with DED *3 DEQS : Dry Eye-related Quality of l...